ERBB2 and breast carcinoma: The only one providing dairy-derived active peptides to 134 women with breast cancer and 267 controls without breast cancer resulted in a reduced risk of ER/PR/HER2-negative breast cancer in Iranian women (Jabbari et al., 2022).